A. K. Setyobudi, V. R. Yudianto, A. S. Hariftyani, and Gatot Soegiarto, “Safety and efficacy of ontamalimab in inflammatory bowel disease: A systematic review and dose- response meta-analysis”, InaJBCS, vol. 57, no. 4, Jan. 2026.